Heron Therapeutics Approval of ZYNRELEF™
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours – ZYNRELEF is the first and only FDA-approved extended-release
View More 
CenExel ACMR Offers COVID-19 Vax
Salt Lake City and Atlanta, Apr. 20, 2021 /GlobeNewswire/ — The Atlanta Center for Medical Research, a CenExel Clinical Research Center of Excellence (“CenExel ACMR”), announced that they will
View More CenExel Acquires CITrials
Salt Lake City, Mar. 9, 2021 /PRNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of CITrials, a southern California-based clinical research firm with three sites serving Los
View More First-In-Human Study of OTO-413
A First-In-Human Study of OTO-413, an Intratympanic Sustained-Exposure Formulation of BDNF, for the Treatment of Speech-in-Noise Hearing Impairment Jeffery J. Anderson(1), James Robinson(1), Alice Blaj(1), Ines Hoffmann(1), Alan Foster(1),
View More
